Watson gears up for generic Lipitor launch

Watson Pharmaceuticals’ (NYSE:WPI) strategy for launching its generic version of Lipitor was the topic of conversation in its third-quarter results as Pfizer’s (NYSE:PFE) exclusive patent to the cholesterol drug nears its expiration date. During Watson’s conference call to discuss its quarterly earnings, CEO Paul Bisaro said: “Regarding the launch of generic Lipitor later this month, […]


Pfizer faces post-Lipitor patent world

Lipitor, Pfizer’s (NYSE: PFE) best-selling drug, could be the first of the statins brought to the over-the-counter market when the company’s patent on it ends Nov. 30, according to Business Week. The news magazine cited comments made by Pfizer’s CEO Ian Read in a conference call discussing the pharmaceutical company’s third-quarter earnings. Pfizer CEO Ian […]